Creative Medical Technology Holdings CELZ
NASDAQ CELZ
$1.01 -0.03 (-2.91%)
As of: Sep 10, 2026 · 11:31 AM EDT

Creative Medical Technology Holdings (CELZ) Net Margin (QoQ) (2018 - 2025)

Analysis

Creative Medical Technology Holdings (CELZ) Net Margin (QoQ) (2018 - 2025) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Krystal Biotech 10.27 Bn 9.43 Bn 112.79 Mn
2 CRISPR Therapeutics AG 5.02 Bn 5.02 Bn -
3 Iovance Biotherapeutics 3.65 Bn 3.35 Bn 55.72 Mn
4 Legend Biotech 3.56 Bn 2.60 Bn 251.50 Mn
5 uniQure 3.00 Bn 3.00 Bn 5.49 Mn
6 Beam Therapeutics 2.54 Bn 2.54 Bn -
7 Precigen 2.36 Bn 2.36 Bn 52.17 Mn
8 Sarepta Therapeutics 2.19 Bn 1.39 Bn 251.87 Mn
9 Vericel 1.96 Bn 1.79 Bn 56.40 Mn
10 Creative Medical Technology Holdings 1.41 Mn 1.41 Mn -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2025 4.46 Mn
Dec 31, 2023 -3.17 Mn
Dec 31, 2022 -3.16 Mn
Mar 31, 2022 -197,921.00
Dec 31, 2021 1.27 Mn
Sep 30, 2021 1.06 Mn
Dec 31, 2020 -22.26 Mn
Sep 30, 2020 711,696.00
Jun 30, 2020 -1.55 Mn
Mar 31, 2020 -11.53 Mn
Dec 31, 2019 12.84 Mn
Sep 30, 2019 -404,133.00
Jun 30, 2019 142,638.00
Mar 31, 2019 -449,641.00
Dec 31, 2018 592,493.00
Sep 30, 2018 13.10 Mn
Jun 30, 2018 -5.50 Mn
Mar 31, 2018 -4.83 Mn